Saving Lives: Australian naloxone access model

The Penington Institute has published a report titled “Saving Lives: Australian naloxone access model”, which coincided with the Therapeutic Goods Administration approving intranasal naloxone for use in Australia. Naloxone reverses opioid overdose, and there is a significant body of evidence from both Australia and overseas that increasing availability of naloxone can reduce fatalities. The Penington report includes a summary of this evidence, along with recommendations to improve access in Australia. Some of the recommendations include providing naloxone free of charge to those at risk of opioid overdose, as well as increasing the number of outlets that can distribute naloxone to include needle and syringe programs, community health services and prisons.

Find out more about “Saving Lives: Australia naloxone access model”